These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 2340312

  • 1. Translocation of exogenous platelet-activating factor and its lyso-compound through plasma membranes is a rate-limiting step for their metabolic conversions into alkylacylglycerophosphocholines in rabbit platelets and guinea-pig leukocytes.
    Tokumura A, Tsutsumi T, Yoshida J, Tsukatani H.
    Biochim Biophys Acta; 1990 May 01; 1044(1):91-100. PubMed ID: 2340312
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Specific receptor sites for 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine (platelet activating factor) on rabbit platelet and guinea pig smooth muscle membranes.
    Hwang SB, Lee CS, Cheah MJ, Shen TY.
    Biochemistry; 1983 Sep 27; 22(20):4756-63. PubMed ID: 6313047
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Metabolism of platelet-activating factor by arachidonic acid-depleted rat polymorphonuclear leukocytes.
    Ramesha CS, Pickett WC.
    J Biol Chem; 1986 Nov 25; 261(33):15519-23. PubMed ID: 3096991
    [Abstract] [Full Text] [Related]

  • 6. Metabolic fate of platelet-activating factor (PAF, 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) and lyso-PAF (1-O-alkyl-2-lyso-sn-glycero-3-phosphocholine) in FRTL5 cells.
    Botitsi E, Mavri-Vavayanni M, Siafaka-Kapadai A.
    J Lipid Res; 1998 Jun 25; 39(6):1295-304. PubMed ID: 9643362
    [Abstract] [Full Text] [Related]

  • 7. Biosynthesis of Paf-acether (platelet-activating factor). VII. Precursors of Paf-acether and acetyl-transferase activity in human leukocytes.
    Jouvin-Marche E, Ninio E, Beaurain G, Tence M, Niaudet P, Benveniste J.
    J Immunol; 1984 Aug 25; 133(2):892-8. PubMed ID: 6736649
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of transmembrane movement and metabolism of platelet activating factor (PAF-acether) by a specific antagonist, BN 52021.
    Lachachi H, Plantavid M, Simon MF, Chap H, Braquet P, Douste-Blazy L.
    Biochem Biophys Res Commun; 1985 Oct 30; 132(2):460-6. PubMed ID: 2998370
    [Abstract] [Full Text] [Related]

  • 9. The metabolism of 1-acyl-PAF in rabbit platelets and its possible interaction with PAF.
    Touqui L, Silva CS, Vargaftig BB.
    Lipids; 1991 Dec 30; 26(12):992-6. PubMed ID: 1819755
    [Abstract] [Full Text] [Related]

  • 10. Metabolism of platelet activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) and 1-alkyl-2-acetyl-sn-glycerol by human endothelial cells.
    Blank ML, Spector AA, Kaduce TL, Lee TC, Snyder F.
    Biochim Biophys Acta; 1986 May 21; 876(3):373-8. PubMed ID: 3707974
    [Abstract] [Full Text] [Related]

  • 11. Regulation of the synthesis of platelet-activating factor and its inactive storage precursor (1-alkyl-2-acyl-sn-glycero-3-phosphocholine) from 1-alkyl-2-acetyl-sn-glycerol by rabbit platelets.
    Lee TC, Malone B, Blank ML, Fitzgerald V, Snyder F.
    J Biol Chem; 1990 Jun 05; 265(16):9181-7. PubMed ID: 2160964
    [Abstract] [Full Text] [Related]

  • 12. The role of Ca2+ in regulating the catabolism of PAF-acether (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) in rabbit platelets.
    Touqui L, Shaw AM, Dumarey C, Jacquemin C, Vargaftig BB.
    Biochem J; 1987 Jan 15; 241(2):555-60. PubMed ID: 3109377
    [Abstract] [Full Text] [Related]

  • 13. Inactivation of platelet activating factor by rabbit platelets. Lyso-platelet activating factor as a key intermediate with phosphatidylcholine as the source of arachidonic acid in its conversion to a tetraenoic acylated product.
    Malone B, Lee T, Snyder F.
    J Biol Chem; 1985 Feb 10; 260(3):1531-4. PubMed ID: 3918041
    [Abstract] [Full Text] [Related]

  • 14. Synthesis of 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet-activating factor) in exocrine glands and its control by secretagogues.
    Söling HD, Fest W.
    J Biol Chem; 1986 Oct 25; 261(30):13916-22. PubMed ID: 3095313
    [Abstract] [Full Text] [Related]

  • 15. Continuous binding of the PAF molecule to its receptor is necessary for the long-term aggregation of platelets.
    Suzuki M, Sugatani J, Ino M, Shimura M, Akiyama M, Yamazaki R, Suzuki Y, Miwa M.
    Am J Physiol; 1998 Jan 25; 274(1):C47-57. PubMed ID: 9458712
    [Abstract] [Full Text] [Related]

  • 16. Conversion of 3H-PAF acether by rabbit platelets is independent from aggregation: evidences for a novel metabolite.
    Touqui L, Jacquemin C, Vargaftig BB.
    Biochem Biophys Res Commun; 1983 Feb 10; 110(3):890-3. PubMed ID: 6838557
    [Abstract] [Full Text] [Related]

  • 17. Non-enzymatic platelet-activating factor formation by acetylated proteins.
    Thanou PG, Tsoukatos DC.
    FEBS Lett; 2004 Aug 27; 573(1-3):11-4. PubMed ID: 15327967
    [Abstract] [Full Text] [Related]

  • 18. Release of platelet-activating factor (PAF-acether) and 2-lyso PAF-acether from three cell types.
    Benveniste J, Roubin R, Chignard M, Jouvin-Marche E, Le Couedic JP.
    Agents Actions; 1982 Dec 27; 12(5-6):711-3. PubMed ID: 7164945
    [Abstract] [Full Text] [Related]

  • 19. 1-O-alkyl-2-acyl-sn-glycero-3-phosphorylcholine is the precursor of platelet-activating factor in stimulated rabbit platelets. Evidence for an alkylacetyl-glycerophosphorylcholine cycle.
    Touqui L, Jacquemin C, Dumarey C, Vargaftig BB.
    Biochim Biophys Acta; 1985 Jan 09; 833(1):111-8. PubMed ID: 3967037
    [Abstract] [Full Text] [Related]

  • 20. Ether lysophospholipid-induced production of platelet-activating factor in human polymorphonuclear leukocytes.
    Sugiura T, Fukuda T, Masuzawa Y, Waku K.
    Biochim Biophys Acta; 1990 Dec 04; 1047(3):223-32. PubMed ID: 2123719
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.